<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Comments on: AstraZeneca to Slash 8,000 More Jobs (Updated 2/3/10)</title>
	<atom:link href="http://blog.pharmexec.com/2010/01/28/astrazeneca-to-slash-8000-more-jobs/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmexec.com/2010/01/28/astrazeneca-to-slash-8000-more-jobs/</link>
	<description>The Business of Pharmaceuticals</description>
	<lastBuildDate>Wed, 08 Feb 2012 14:53:10 -0500</lastBuildDate>
	
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Yolanda Cooper</title>
		<link>http://blog.pharmexec.com/2010/01/28/astrazeneca-to-slash-8000-more-jobs/comment-page-1/#comment-57304</link>
		<dc:creator>Yolanda Cooper</dc:creator>
		<pubDate>Thu, 04 Feb 2010 14:33:00 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmexec.com/?p=1357#comment-57304</guid>
		<description>How is overall picture looking for reps in general.  Is there any hope for new comers in the field? Should they pursue or sit back for while because of all the cuts backs?</description>
		<content:encoded><![CDATA[<p>How is overall picture looking for reps in general.  Is there any hope for new comers in the field? Should they pursue or sit back for while because of all the cuts backs?</p>
]]></content:encoded>
	</item>
</channel>
</rss>

